VivoSeq
Other

Intensive Care Unit

1

Pipeline Programs

9

Active Trials

2

Companies Involved

Intensive Care Unit is an early-stage landscape with 1 program across 2 companies. The most active players are Pfizer, GSK.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs

Trial Status

82

clinical trials

Completed48 · 59%
Unknown status17 · 21%
Terminated6 · 7%
Recruiting6 · 7%
Not yet recruiting3 · 4%
Withdrawn2 · 2%

Trial Activity

82 trials

Vasoactive Drugs in Intensive Care Unit
Recruiting·UUniversity of Chicago·Phase 4·NCT02118467·836 enrolled
Cenobamate in the Intensive Care Unit
Not yet recruiting··Phase 1·NCT06352723·10 enrolled
Nicotine Replacement Therapy in the Intensive Care Unit
Completed··Phase 4·NCT01362959·47 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)